The kit gives results in less than 50 minutes
Genes2Me, one of India’s leading IVD manufacturers, ahas developed the Real-Time PCR-based kit for quick detection of Monkeypox virus with a fast turnaround result time of less than 50 minutes. This kit is available in both the standard version for any commonly available Real Time PCR instruments as well as Point-of-Care format on Genes2Me Rapi-Q HT Rapid RT-PCR device. The Point-of-Care solution can be used for screening at multiple sites including Hospitals, Airports, Diagnostic Labs, Health Camps, etc.
Scientists from Genes2Me have been able to develop ‘POX-Q Multiplexed RT-PCR kit’ for the detection of the Monkeypox virus along with differentiation from Varicella Zoster Virus (Chicken Pox) in a single tube multiplex reaction format. The first-of-its-kind ‘Made in India’ product, this kit is available as Research-Use only (RUO) and based on Gold standard Taqman chemistry-based RT PCR method.
“This unprecedented time underscores the importance of diagnostic assays in health security preparedness and readiness. We wanted to be prepared ahead of time for this virus. Understanding the value of time, we have launched this RT PCR for Monkeypox which will give the result in less than 50 minutes with the highest accuracy. We have the current capacity to manufacture five million test kits in a week, however, it can be scaled up to two million tests in a day with the added demand, said Neeraj Gupta, CEO and Founder, Genes2Me.
He also highlighted that the Genes2Me team also introduced “RT-Direct” as the first Made-in-India COVID-19 Extraction Free RT-PCR Kit, with coverage of three targets specific for SARS-CoV-2 which give results in less than 40 minutes.
